DFCI 11-237: A Feasibility trial of Everolimus (RAD001), an mTOR inhibitor, given in combination with multiagent re-induction chemotherapy in pediatric patients with relapsed acute lymphoblastic Leukemia (ALL)
- Hijiya, Nobuko (PD/PI)
Project: Research project